BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2010
View Archived Issues
Synergy seen with topiramate and amantadine in model of levodopa-induced dyskinesia
Read More
TC-5214 shows benefit as add-on to citalopram in major depression
Read More
Merck & Co. discloses new soluble guanylate cyclase activators
Read More
LEAD Therapeutics claims novel antibacterial agents
Read More
Bayer Schering claims new imaging agents to monitor tumors
Read More
Organon claims cannabinoid CB2 receptor agonists as analgesics
Read More
Novel PDK1 inhibitors claimed by MSD for cancer therapy
Read More
Trastuzumab to receive priority review for expanded indications in Japan
Read More
Kowa Pharmaceuticals America and Lilly launch Livalo in the U.S.
Read More
IMB-007 shows promise as neuropathic pain therapy
Read More
Phase II data support use of florbetaben to diagnose AD using PET
Read More
TH-302/doxorubicin combination is safe in phase I/II trial in soft tissue sarcoma
Read More
CAT-8015 is evaluated in phase I trial in hairy cell leukemia
Read More
FDA approves diagnostic Architect HIV Ag/Ab combo assay
Read More
Nanoviricides potent against dengue virus infection in initial in vivo studies
Read More
Cellceutix concludes preclinical studies of Kevetrin in multidrug-resistant cancer cells
Read More
Palatin reports preclinical data on PL-3994 for asthma indications
Read More
OncoGenex begins phase III custirsen sodium trial in metastatic prostate cancer
Read More
Ferring launches Lysteda for heavy menstrual bleeding in the U.S.
Read More
Pharmaxis reports on second phase III trial of Bronchitol in CF
Read More
Nymox nears completion of follow-up study of NX-1207 for BPH
Read More
StemEx receives FDA fast track designation
Read More
GW launches Sativex spray in the U.K. for spasticity due to MS
Read More
FDA approves Namenda XR for Alzheimer's-type dementia
Read More
Sanofi-aventis and Regulus collaborate on microRNA therapeutics
Read More
Eisai's anticancer agent eribulin mesilate receives priority review status in Japan
Read More